| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |